Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Quercetin prevents left ventricular hypertrophy in the Apo E knockout mouse.

Ulasova E, Perez J, Hill BG, Bradley WE, Garber DW, Landar A, Barnes S, Prasain J, Parks DA, Dell'Italia LJ, Darley-Usmar VM.

Redox Biol. 2013 Jul 16;1:381-6. doi: 10.1016/j.redox.2013.07.001. eCollection 2013.

2.

Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.

Ruetten H, Dimmeler S, Gehring D, Ihling C, Zeiher AM.

Cardiovasc Res. 2005 Jun 1;66(3):444-53. Epub 2005 Feb 24.

PMID:
15914109
3.

Dietary quercetin attenuates oxidant-induced endothelial dysfunction and atherosclerosis in apolipoprotein E knockout mice fed a high-fat diet: a critical role for heme oxygenase-1.

Shen Y, Ward NC, Hodgson JM, Puddey IB, Wang Y, Zhang D, Maghzal GJ, Stocker R, Croft KD.

Free Radic Biol Med. 2013 Dec;65:908-15. doi: 10.1016/j.freeradbiomed.2013.08.185. Epub 2013 Sep 7.

PMID:
24017971
4.

Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.

Janssens S, Pokreisz P, Schoonjans L, Pellens M, Vermeersch P, Tjwa M, Jans P, Scherrer-Crosbie M, Picard MH, Szelid Z, Gillijns H, Van de Werf F, Collen D, Bloch KD.

Circ Res. 2004 May 14;94(9):1256-62. Epub 2004 Mar 25.

5.

Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency.

Ichinose F, Bloch KD, Wu JC, Hataishi R, Aretz HT, Picard MH, Scherrer-Crosbie M.

Am J Physiol Heart Circ Physiol. 2004 Mar;286(3):H1070-5. Epub 2003 Nov 26.

6.

Cardiac remodeling and contractile function in acid alpha-glucosidase knockout mice.

Kamphoven JH, Stubenitsky R, Reuser AJ, Van Der Ploeg AT, Verdouw PD, Duncker DJ.

Physiol Genomics. 2001 Apr 27;5(4):171-9.

PMID:
11328962
7.

Effects of adiponectin deficiency on structural and metabolic remodeling in mice subjected to pressure overload.

O'Shea KM, Chess DJ, Khairallah RJ, Rastogi S, Hecker PA, Sabbah HN, Walsh K, Stanley WC.

Am J Physiol Heart Circ Physiol. 2010 Jun;298(6):H1639-45. doi: 10.1152/ajpheart.00957.2009. Epub 2010 Mar 26.

8.

A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone.

López-Andrés N, Martin-Fernandez B, Rossignol P, Zannad F, Lahera V, Fortuno MA, Cachofeiro V, Díez J.

Am J Physiol Heart Circ Physiol. 2011 Dec;301(6):H2372-82. doi: 10.1152/ajpheart.00283.2011. Epub 2011 Sep 16.

9.

Impact of chronic use of cibenzoline on left ventricular pressure gradient and left ventricular remodeling in patients with hypertrophic obstructive cardiomyopathy.

Hamada M, Ikeda S, Ohshima K, Nakamura M, Kubota N, Ogimoto A, Shigematsu Y.

J Cardiol. 2016 Mar;67(3):279-86. doi: 10.1016/j.jjcc.2015.05.014.

10.

Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.

Garcia AG, Wilson RM, Heo J, Murthy NR, Baid S, Ouchi N, Sam F.

Am J Physiol Heart Circ Physiol. 2012 Sep 1;303(5):H587-96. doi: 10.1152/ajpheart.00298.2012. Epub 2012 Jun 22.

11.

Na+/H+ exchange inhibition attenuates left ventricular remodeling and preserves systolic function in pressure-overloaded hearts.

Marano G, Vergari A, Catalano L, Gaudi S, Palazzesi S, Musumeci M, Stati T, Ferrari AU.

Br J Pharmacol. 2004 Feb;141(3):526-32. Epub 2004 Jan 12.

12.

Inhibition of left ventricular remodelling preserves chamber systolic function in pressure-overloaded mice.

Marano G, Palazzesi S, Vergari A, Catalano L, Gaudi S, Testa C, Canese R, Carpinelli G, Podo F, Ferrari AU.

Pflugers Arch. 2003 Jul;446(4):429-36. Epub 2003 Apr 25.

PMID:
12715181
13.

Paradoxical effects of fenofibrate and nicotinic acid in apo E-deficient mice.

Declercq V, Yeganeh B, Moshtaghi-Kashanian GR, Khademi H, Bahadori B, Moghadasian MH.

J Cardiovasc Pharmacol. 2005 Jul;46(1):18-24.

PMID:
15965350
14.

The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload.

Meems LM, Cannon MV, Mahmud H, Voors AA, van Gilst WH, Silljé HH, Ruifrok WP, de Boer RA.

J Steroid Biochem Mol Biol. 2012 Nov;132(3-5):282-9. doi: 10.1016/j.jsbmb.2012.06.004. Epub 2012 Jul 16.

PMID:
22800987
15.

Left ventricular geometry and arterial function in hypercholesterolemia.

Celentano A, Crivaro M, Roman MJ, Pietropaolo I, Greco R, Pauciullo P, Lirato C, Devereux RB, de Simone G.

Nutr Metab Cardiovasc Dis. 2001 Oct;11(5):312-9.

PMID:
11887428
16.

Effect of angiotensin type I-receptor blockade on left ventricular remodeling in pressure overload hypertrophy.

Kiatchoosakun S, Lawrence E, Nakada S, Restivo J, Walsh RA, Hoit BD.

J Card Fail. 2001 Dec;7(4):342-7.

PMID:
11782858
17.

Heart failure in pressure overload hypertrophy. The relative roles of ventricular remodeling and myocardial dysfunction.

Norton GR, Woodiwiss AJ, Gaasch WH, Mela T, Chung ES, Aurigemma GP, Meyer TE.

J Am Coll Cardiol. 2002 Feb 20;39(4):664-71.

18.
19.

Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice.

Scherrer-Crosbie M, Ullrich R, Bloch KD, Nakajima H, Nasseri B, Aretz HT, Lindsey ML, Vançon AC, Huang PL, Lee RT, Zapol WM, Picard MH.

Circulation. 2001 Sep 11;104(11):1286-91.

20.

Supplemental Content

Support Center